Genetic landscape of FLT3-mutated acute myeloid leukemia (AML) patients treated within the ratify trial (Alliance C10603)
- Citation:
- HemaSphere vol 3 (suppl 1) 436
- Meeting Instance:
- EHA 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Novartis
- Grants:
- U10CA180821, U10CA180861, U10CA180882, U24CA196171, U10CA180820 (ECOG-ACRIN), U10CA180863 (CCTG), U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Nikolaus Jahn Ekaterina Panina Lars Bullinger Anna Dolnik Julia Herzig Tamara J. Blätte Axel Benner Julia Krzykalla Insa Gathmann Richard A. Larson Francesco Lo-Coco Sergio Amadori Thomas W. Prior Joseph M. Brandwein Frederick R. Appelbaum Bruno C. Medeiros Martin S. Tallman Eva Tiecke Celine Pallaud Gerhard Ehninger Michael Heuser Arnold Ganser Richard M. Stone Christian Thiede Hartmut Döhner Clara D. Bloomfield Konstanze Döhner
- Networks:
- LAPS-IL036, LAPS-IL057, LAPS-MA036
- Study
- CALGB-10603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: